WHO updates global catalogue for interpreting tuberculosis drug resistance mutations

WHO
Nov 10, 2026

WHO updates global catalogue for interpreting tuberculosis drug resistance mutations


The World Health Organization (WHO) today published the third edition of the Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance, providing the most comprehensive global reference to date for interpreting genomic mutations associated with drug-resistant tuberculosis (TB).

The updated catalogue strengthens the evidence base for molecular and sequencing-based drug resistance testing for TB, supporting more consistent interpretation and use of genomic data across laboratories, surveillance programmes, diagnostic developers and researchers worldwide.

"Rapid and accurate detection of drug resistance is essential to ensuring that people with tuberculosis receive the most effective treatment as early as possible,” said Dr Tereza Kasaeva, Director of WHO’s Department for HIV, TB, Hepatitis and Sexually Transmitted Infections. “As targeted next-generation sequencing technologies become increasingly accessible, this third edition substantially expands the global evidence available for interpreting drug resistance, including for newer and repurposed medicines, while strengthening guidance to support the consistent application of genomic results in practice."